Next Article in Journal
Toll-like Receptor Agonists Are Unlikely to Provide Benefits in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
Next Article in Special Issue
DNA Double-Strand Break Response and Repair Gene Polymorphisms May Influence Therapy Results and Prognosis in Head and Neck Cancer Patients
Previous Article in Journal
Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or BRAF/MEK Targeted Therapy: Multicenter Real-World Report
 
 
Article

Article Versions Notes

Cancers 2023, 15(17), 4385; https://doi.org/10.3390/cancers15174385
Action Date Notes Link
article xml file uploaded 1 September 2023 15:33 CEST Original file -
article xml uploaded. 1 September 2023 15:33 CEST Update https://www.mdpi.com/2072-6694/15/17/4385/xml
article pdf uploaded. 1 September 2023 15:33 CEST Version of Record https://www.mdpi.com/2072-6694/15/17/4385/pdf
article supplementary file uploaded. 1 September 2023 15:33 CEST - https://www.mdpi.com/2072-6694/15/17/4385#supplementary
article html file updated 1 September 2023 15:35 CEST Original file https://www.mdpi.com/2072-6694/15/17/4385/html
Back to TopTop